Press Review - May 30, 2014 Invokana: first sodium-glucose co-transporter 2 inhibitor for type 2 diabetesReduces plasma glucose by decreasing renal reabsorption and increasing urinary excretion of glucose. Fore: 10th annual Ontario Medical Students Bursary Fund golf fundraiser today! Drug News: May 2014 A review of launches, new indications, Health Canada advisories and new dosage guidelines OPA urges members to support parties that share profession’s vision Association puts forward three priorities to promote to all party candidates. Stateside: Pharmacist convicted of murder appeals life sentence Lawyer claims new evidence explains why Jerome Ersland thought he was being shot at. Clinicians advancing digital health in Canada for better patient care Specialty drug spend unsustainable Spending on specialty drugs is likely to increase at a significant rate, substantially impacting the cost employers pay, according to a report. Fentanyl scam uncovered in Ontario Health centre receptionist sentenced to nine years would verify forged prescriptions when pharmacies called to double-check orders. Europe: Pharmacy's closure exposes holes in U.K. care home supply Drugstores scramble to fill void left by bankruptcy of Pharmacy Plus. First Previous 2941 2942 2943 2944 2945 Next Last
